540
Views
11
CrossRef citations to date
0
Altmetric
Innovation

Design of an effective piezoelectric microcantilever biosensor for rapid detection of COVID-19

, &
Pages 423-433 | Received 13 Dec 2020, Accepted 19 Apr 2021, Published online: 17 May 2021

References

  • Olwenyi OA, Dyavar SR, Acharya A, et al. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med. 2020;98(10):1315–1369.
  • Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci. 2020;50(SI-1):563–570.
  • Nguyen TT, Pathirana PN, Nguyen T, et al. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus). Sci Rep. 2021;11(1):1–16.
  • Kotlyar A, Grechukhina O, Chen A, et al. Vertical transmission of COVID-19: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;224(1):35–53.e3.
  • Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int Med. 2020;172(9):577–582.
  • Forni G, Mantovani A. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28(2):626–639.
  • Dos Santos WG. Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines. Biomed Pharmacother. 2021;136:111272.
  • Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. Nature. 2021;7:10.
  • Shen X, Tang H, McDanal C, et al. SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. Cell Host Microbe. 2021;29(4):529–539.e3.
  • Heinz FX, Stiasny K. Profiles of current COVID-19 vaccines. Wiener Klinische Wochenschrift. 2021;133(7):271–283.
  • Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2020;21(2):73–82.
  • Badua CLD, Baldo KAT, Medina PMB. Genomic and proteomic mutation landscapes of SARS‐CoV‐2. J Med Virol. 2021;93(3):1702–1721.
  • Cui F, Zhou HS. Diagnostic methods and potential portable biosensors for coronavirus disease 2019. Biosens Bioelectron. 2020;165:112349.
  • Li C, Ren L. Recent progress on the diagnosis of 2019 Novel Coronavirus. Transbound Emerg Dis. 2020;67(4):1485–1491.
  • Imai K, Tabata S, Ikeda M, et al. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. J Clin Virol. 2020;128:104393.
  • Pan Y, Li X, Yang G, et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020;81(1):e28–e32.
  • Seo G, Lee G, Kim MJ, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14(4):5135–5142.
  • Kim HH, Jeon HJ, Cho HK, et al. Highly sensitive microcantilever biosensors with enhanced sensitivity for detection of human papilloma virus infection. Sens Actuators B. 2015;221:1372–1383.
  • Gopinath PG, Anitha VR, Mastani SA. Design and simulation of high sensitive paddle microcantilever sensor for biosensing. Proceedings of the2017 International Conference on Energy, Communication, Data Analytics and Soft Computing (ICECDS) (pp. 2907–2910). IEEE; 2017.
  • Wee KW, Kang GY, Park J, et al. Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers. Biosens Bioelectron. 2005;20(10):1932–1938.
  • Rasmussen PA, Thaysen J, Hansen O, et al. Optimised cantilever biosensor with piezoresistive read-out. Ultramicroscopy. 2003;97(1–4):371–376.
  • Sepaniak M, Datskos P, Lavrik N, et al. 2002. Peer reviewed: microcantilever transducers: a new approach in sensor technology. Anal Chem. 74(21):568A–575A.
  • Senesac LR, Dutta P, Datskos PG, et al. Analyte species and concentration identification using differentially functionalized microcantilever arrays and artificial neural networks. Anal Chim Acta. 2006;558(1–2):94–101.
  • Saurabh NK, Badri D, Rudraswamy SB. Design of microcantilever sensor for detection of P24 antigen in HIV diagnoses. Int J Sci Eng Sci. 1(12):44–47.
  • Velanki S, Ji HF. Detection of feline coronavirus using microcantilever sensors. Meas Sci Technol. 2006;17(11):2964–2968.
  • Katsouras I, Asadi K, Li M, et al. The negative piezoelectric effect of the ferroelectric polymer poly (vinylidene fluoride). Nature Mater. 2016;15(1):78–84.
  • Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2021;54(2):159–163.
  • Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19. Allergy. 2020;75(7):1564–1581.
  • Zhang P, Gao Q, Wang T, et al. Evaluation of recombinant nucleocapsid and spike proteins for serological diagnosis of novel coronavirus disease 2019 (COVID-19). MedRxiv. 2020:2020.03.17.20036954.
  • Giron CC, Laaksonen A, da Silva FLB. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. Virus Res. 2020;285:198021.
  • Yu F, Yan L, Wang N, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020;71(15):793–798.
  • Liu X, Wang J, Xu X, et al. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020;9(1):1269–1274.
  • Ma H, Zeng W, He H, et al. COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by chemiluminescence immunoanalysis. medRxiv. 2020.
  • Hou H, Wang T, Zhang B, et al. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin Transl Immunol. 2020;9(5):e1136.
  • Wu Y, Wang F, Shen C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368(6496):1274–1278.
  • Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211(1):80–90.
  • Valk SJ, Piechotta V, Chai KL, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review. Cochrane Database Syst Rev. 2020;(5):CD013600.
  • Fan G, Wang Z, Hao M, et al. Bispecific antibodies and their applications. J Hematol Oncol. 2015;8(1):130.
  • Marston HD, Paules CI, Fauci AS. Monoclonal antibodies for emerging infectious diseases—borrowing from history. N Engl J Med. 2018;378(16):1469–1472.
  • Walker LM, Burton DR. Passive immunotherapy of viral infections:' super-antibodies' enter the fray. Nat Rev Immunol. 2018;18(5):297–308.
  • Jaffe B. 2012. Piezoelectric ceramics (Vol. 3). Elsevier Science. London: Academic Press.
  • Ounaies Z, Young JA, Harrison JS. An overview of the piezoelectric phenomenon in amorphous polymers. Field responsive polymers. ACS Symposium Series. 726: American Chemical Society; 1999. p. 88–103.
  • Kawai H. The piezoelectricity of poly (vinylidene fluoride). Jpn J Appl Phys. 1969;8(7):975–976.
  • Calleja M, Tamayo J, Johansson A, et al. Polymeric cantilever arrays for biosensing applications. Sen Lett. 2003;1(1):20–24.
  • Cheng HM, Ewe MT, Chiu GT, et al. Modeling and control of piezoelectric cantilever beam micro-mirror and micro-laser arrays to reduce image banding in electrophotographic processes. J Micromech Microeng. 2001;11(5):487–498.
  • Zhou W, Khaliq A, Tang Y, et al. Simulation and design of piezoelectric microcantilever chemical sensors. Sens Actuators A. 2005;125(1):69–75.
  • Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty. 2020;35(7):S74–S81.
  • Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Physician. 2019;100(12):751–758.
  • Lee CC, Yang CY, Lin LL, et al. An effective neutralizing antibody against influenza virus H1N1 from human B cells. Sci Rep. 2019;9(1):1–11.
  • Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance. Geneva: World Health Organization; 2020 [accessed 2020 Nov 18]. https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.